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Effects of oestrogen administration on vitamin B, and tryptophan 
metabolism in the rat 
BY DAVID A. BENDER, C L E M E N T  E. TAGOE* A N D  JUSTIN A. VALE 
Courtauld Institute of Biochemistry, The Middlesex Hospital Medical School, 
London Wl P 7PN 
(Received 2 September 1981 -Accepted 11 November 1981) 
1. In order to assess the effects of oestrogens on the metabolism of tryptophan and vitamin B,, ovariectomized 
rats have been maintained on diets providing known amounts of tryptophan, nicotinamide and vitamin B,. They 
received oestrone sulphate, 210 pg/kg body-wt per d, either incorporated in the diet for 8 weeks, or by daily 
intraperitoneal injection for periods of 1-3 d. 
2. Oestrone sulphate administration caused a slight reduction in the concentration of pyridoxal phosphate in 
plasma. It had no effect on the concentration of pyridoxal phosphate in liver or kidney, the urinary excretion 
of 4-pyridoxic acid, the activation of erythrocyte aspartate aminotransferase (L-aspartate: 2-oxo-glutarate 
aminotransferase, EC2 .6 .  I . I )  by incubation with added pyridoxal phosphate, or the activity of pyridoxal oxidase 
(a1dehyde:oxygen oxido-reductase, EC I . 2 .3 .1 )  in the liver. 
3. Oestrone sulphate administration caused an increase in the urinary excretion of kynurenine and a reduction 
in the activity of liver kynureninase (r-kynurenine hydrolase, EC3 . 7  . 1 .3) .  It had no effect on the urinary excretion 
of N1-methyl nicotinamide or the concentrations of nicotinamide nucleotides in blood, liver or kidney. 
4. There was a considerable excess of the apoenzyme of kynureninase in the liver. Incubation of liver 
homogenates with added pyridoxal phosphate led to a 4- to 5-fold increase in activity. 
5. We conclude that there is no evidence of any significant effect of oestrogens on vitamin B,. It is suggested 
that abnormalities of tryptophan metabolism in women receiving oestrogens, which have been widely attributed 
to drug-induced vitamin B, depletion, can be accounted for by inhibition of kynureninase by oestrogen metabolites. 
It is widely believed that oestrogens, given as oral contraceptives or as menopausal hormone 
replacement therapy, cause depletion of vitamin B,. Rose & Braidman (1971) reviewed a 
number of reports of abnormal tryptophan metabolism, indicative of vitamin B, deficiency, 
in women receiving contraceptive steroids. Rose & Adams (1972) showed that the 
administration of supplementary vitamin B, to such women would restore tryptophan 
metabolism to normal. Other studies (Brown et al. 1975; Leklem et al. 1975) have similarly 
shown impaired tryptophan metabolism in response to oestrogen administration in women 
consuming controlled'diets providing known amounts of vitamin B,. 
All these studies have depended on the use of the tryptophan load test as an indicator of 
vitamin B, status. The enzyme kynureninase (L-kynurenine hydrolase, EC 3 . 7 . 1  .3) is 
pyridoxal phosphate dependent, and in deficiency of the vitamin its activity is impaired, 
leading to increased excretion of kynurenic and xanthurenic acids and kynurenine after 
administration of a test dose of tryptophan (Coursin, 1964). The use of the tryptophan load 
test in such cases can be criticized on the grounds that inhibition of kynureninase by 
oestrogens or their metabolites would give results indistinguishable from vitamin B, 
deficiency. Such inhibition has been demonstrated (Bender & Wynick, 1981). 
A number of studies cast further doubt on the interpretation of an abnormal response 
to a test dose of tryptophan as oestrogen-induced vitamin B, deficiency, since other 
indicators of vitamin B, status are unaffected by oestrogen administration. Leklem et al. 
(1975) showed no effect of oestrogens on the metabolism of a test dose of methionine. The 
plasma concentration of pyridoxal phosphate and urinary excretion of 4-pyridoxic acid are 
also unaffected by use of either oral contraceptives (Brown et al. 1975; Leklem et al. 1975) 
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or menopausal hormone replacement therapy (Bender et al. 198 1). The activation of plasma 
or erythrocyte aspartate or alanine aminotransferase by incubation with added pyridoxal 
phosphate has yielded conflicting results; some workers have shown effects that suggest 
vitamin B, deficiency in response to oestrogens (Aly et al. 1971 ; Salkeld et al. 1973), while 
others have been unable to demonstrate any effect (Rose & Adams, 1972; Leklem et al. 
1975; Wien, 1978). 
The present study was designed to determine whether there is any depletion of vitamin 
B, in response to oestrogen administration, and to what extent the abnormalities of 
tryptophan metabolism that have been reported in clinical studies reflect inhibition of 
kynureninase by oestrogen metabolites. A number of different indicators of the metabolism 
of tryptophan and vitamin B, have been assessed in rats that were maintained on diets 
providing known amounts of tryptophan, nicotinamide and vitamin B,. Ovariectomized 
rats were used so as to avoid complications due to endogenous oestrogen secretion. The 
results indicate that oestrogens do not cause depletion of vitamin B,, and that all of the 
effects on tryptophan metabolism can be accounted for by inhibition of kynureninase. 
M E T H O D S  
Animals and diets 
Female Wistar rats, bred in the Courtauld Institute, were used. They were weaned at 21 d 
of age onto a diet similar to that described by Bender et al. (1982), providing (mg/kg dry 
matter (DM)): 1300 tryptophan, 2 nicotinamide, 1.2 pyridoxine hydrochloride. All animals 
were maintained on this diet throughout the experiment. 
Ater 2 weeks, the rats were bilaterally ovariectomized under anaesthesia with Valium 
(Roche; Diazepam 2.5 mg/kg body-wt (BW), intraperitoneally) and Hypnorm (Janssen; 
(mg/kg BW) fentanyl citrate 0.315, fluanisone 10, intramuscularly). For the first 3 d after 
operation they were provided with a solution of oxytetracycline (Pfizer, Terramycin syrup; 
2.5 mg/ml) in the drinking water. 
Between 3-4 weeks after ovariectomy, animals were treated with oestrone sulphate, 
210 ,ug/kg BW per d in 0.15 M-sodium chloride (saline) by intraperitoneal injection daily 
for 1-3 d. This is approximately three times the dose of oestrone sulphate that is used 
clinically as menopausal hormone replacement therapy. Control animals received injections 
of saline alone. A further group of animals was treated with oestrone sulphate for 8 weeks, 
beginning 2 weeks after ovariectomy. In this group the hormone was incorporated in the 
diet at a concentration of 3 mg/kg DM; from the observed consumption of 70 g dietary 
DM/kg BW per d this would provide the same dose of 210 ,ug/kg BW per d as in the acute 
study. 
For 24 h before killing, the rats were housed individually in stainless-steel metabolism 
cages (Acme Metal Co Inc, Chicago, Ill., USA) to permit collection of urine. No preservative 
was added, and the urine was stored at -20' until it was required. The rats were killed 
by decapitation, and blood was collected into heparinized beakers on ice. One sample was 
used immediately for the determination of nicotinamide nucleotides, and the remainder was 
centrifuged (2000 g, 20 min); plasma was frozen and stored at - 20'. Erythrocytes were 
washed with saline, then lysed in a volume of distilled water equal to the plasma volume; 
the lysate was frozen and stored at - 20'. Liver and kidneys were dissected out and frozen 
in liquid nitrogen and were used within 2 h, and the remainder was stored at -2OO. 
Uteri were dissected out and inspected to ensure that those animals that had received 
oestrone sulphate were indeed adequately oestrogenized, as shown by considerable uterine 
enlargement compared with the control animals. Any animal in which a partial ovary was 
visible, indicating inadequate ovariectomy, was discarded. 
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Analytical methods 
The total concentration of nicotinamide nucleotides (a combined estimate of the oxidized 
and reduced forms of NAD and NADP) in blood, liver and kidney was measured after 
treatment with or homogenization in dilute hydrogen peroxide solution, by the fluorimetric 
method that has been described by Bender et al. (1982). 
The concentration of pyridoxal phosphate in plasma, liver and kidney was determined 
by the fluorimetric method of Adams (1979), after denaturation of proteins with 
110 g trichloroacetic acid/l. 
The concentration of tryptophan in plasma was measured by a modification of the 
norharman fluorimetric method (Denckla & Dewey, 1967), using perchloric acid rather than 
trichloroacetic acid. 
Urine 4-pyridoxic acid was determined by the lactone fluorimetric method of Reddy et 
al. (1958) after ion-exchange chromatography on columns of Dowex 1 (OH-) and Dowex 
50W (H+) resins. 
Urine kynurenine was determined by the colorimetric method of Joseph & Risby (1975) 
after ion-exchange chromatography on columns of Dowex 50W (H+) resin as described by 
Satoh & Price (1958). 
Urine N1-methyl nicotinamide was determined by a small-scale modification of the 
alkali-ketone fluorimetric method of Carpenter & Kodicek (1950), as described previously 
(Bender, 1980). 
The activity of kynureninase in liver was measured by the fluorimetric method of Bender 
& Smith (1978), both with and without the addition of pyridoxal phosphate to a final 
concentration of 1 mmol/l in the incubation mixture, in order to assess both the holoenzyme 
and total (holoenzyme + apoenzyme) content of the tissue. 
The activity of pyridoxal oxidase (aldehyde: oxygen oxido-reductase, EC 1 .2 .3 .1)  in 
liver was measured by the following modification of the method of Stanulovic & Chaykin 
(1971). Liver was homogenized while still frozen in 2 ml saline/g tissue, and the homogenate 
was centrifuged at 20000g for 30 min to remove cell debris, nuclei and mitochondria. 
Samples of the supernatant fraction (1 ml) were incubated at 30° with 1 ml 0.1 M-sodium 
phosphate, pH 7.0 and 100 p1 10 mM-pyridoxine hydrochloride for 30 min, with vigorous 
shaking to ensure adequate oxygenation. The reaction was stopped by the addition of 1 ml 
1 M-trichloroacetic acid in 5 M-hydrochloric acid, and samples were centrifuged to remove 
denatured protein (2000 g, 20 min). The amount of 4-pyridoxic acid formed was measured 
by the lactone fluorimetric method of Reddy et al. (1958). 
The activity of aspartate aminotransferase (L-aspartate : 2-oxo-glutarate aminotransferase, 
EC 2 . 6 .  1 . 1) in the erythrocyte lysate was measured both with and without the addition 
of pyridoxal phosphate to a final concentration of 1 mmol/l, by the following modification 
of the method of Schuster et al. (1978). A 100 p1 sample of the lysate was incubated with 
loop1 0.2 M-sodium phosphate, pH 7.5 in which pyridoxal phosphate was dissolved as 
appropriate, for 10 min at 30'. The reaction was initiated by the addition of 100 pl of a 
- solution of 0.1 M-2-oxo-glutarate and 0.05 ~-[2,3-~H]aspartate (0.5 Ci/mol), and allowed 
to continue for 15 min. The reaction was stopped by immersing the tubes in a boiling 
water-bath for 2 min; they were then cooled, diluted with 200 pl water and centrifuged at 
2000 g for 20 min to remove denatured protein. The substrate was tritiated in those atoms 
that were lost as water during the transamination reaction, so that measurement of the 
amount of 3 H , 0  formed would reflect the activity of the enzyme. Unreacted 13H]aspartate 
was removed from the reaction mixture by pouring the supernatant fraction onto columns 
of finely-pulverized Zerolit DMF mixed-bed ion-exchange resin (approximately 300 mg 
resin per column), followed by washing with 1 ml water. The eluate was then mixed with 
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Table 1. The effects on vitamin B, and tryptophan metabolism of the administration of 
oestrone sulphate (210 ,ug/kg body-weight per d )  to rats 
(Mean values and standard deviations; no. of animals in parentheses) 
Oestrone sulphate 
administration 
Control 
(36) 
Treatment Mean SD 
Pyridoxal phosphate 
Plasma ( p ~ )  
Liver (,umol/g) 
Kidney @mol/g) 
Activation of erythrocyte aspartate 
aminotransferase by 1 mhf-pyridoxal phosphate 
(activated: basal) 
Urine 4-pyridoxic acid (nmo1/24 h) 
Liver pyridoxal oxidase (nmol product 
Plasma tryptophan @M) 
Urine kynurenine (nmo1/24 h) 
Urine N1-methyl nicotinamide (nmo1/24 h) 
Nicotinamide nucleotides 
formed/min per g) 
Blood @M) 
Liver (,umol/g) 
Kidney (pmol/g) 
formed/min per g) : 
Liver kynureninase (nmol product 
N o  added pyridoxal phosphate 
+ 1 mM-pyridoxal phosphate 
0.65 0.31 
15.6 4.0 
18.9 6.7 
1.21 0.16 
49.9 15.1 
0.1 I 5  0,039 
59.2 24.1 
5.9 0.3 
21.9 5.4 
73.0 12.3 
0.42 0.15 
0.77 0.20 
5.67 1.15 
21.9 5.4 
1-3 d 8 weeks 
(28) (8) 
Mean SD Mean SD 
- 
0.52 0.21* 
15.6 4.3 
21.9 5.8 
1.15 0.14 
49.0 18.8 
0.119 0.035 
53.6 25.0 
7.2 2.2** 
23.1 4.6 
74.3 14.5 
0.43 . 0.20 
0.84 0.35 
0.48 0.14 
15.3 2.3 
16.5 3.3 
1.24 0.15 
51.8 17.4 
0.105 0.029 
7.9 I. l*** 
17.2 21,3* 
19.4 2.1 
81.0 18.4 
0.53 0.39 
0.82 0.22 
4.53 0.80*** 4.40 0.80*** 
23.1 4.6 19.4 2.1 
Statistical significance of differences by t test: * 0.1 2 P 2 0.05, ** 0.005 2 P 2 0.001, *** P < 0.001. 
15 ml scintillator solution (9 g PPO+60 mg POPOP in 600 ml Triton X-100+ 1800 ml 
toluene). Radioactivity was measured using a Packard TriCarb liquid-scintillation 
spectrometer. 
RESULTS 
Analysis of variance showed no significant effect of the time of treatment with oestrone 
sulphate for 1, 2 or 3 d, and no significant effect of the age of the rats, on any criteria 
measured. For this reason, the results in Table 1 show a single group of control animals; 
those animals that received oestrone sulphate for 1, 2 or 3 d by intraperitoneal injection 
have similarly been grouped together. Those animals that received oestrone sulphate in the 
diet for 8 weeks have been considered separately because of the different mode of 
administration of the hormone. 
Short-term treatment with oestrone sulphate led to a slight fall in the plasma concentration 
of pyridoxal phosphate (0.1 > P > 0.05); after treatment for 8 weeks, the concentration 
was again lower than in control animals, but the difference was not significant by t test. 
Neither group of oestrone sulphate-treated animals showed any significant difference from 
controls in the concentration of pyridoxal phosphate in liver or kidney, the urinary excretion 
of 4-pyridoxic acid, the activity of pyridoxal oxidase in the liver or the activation of 
erythrocyte aspartate aminotransferase by incubation with added pyridoxal phosphate. 
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Administration of oestrone sulphate for 8 weeks, but not for 1-3 d, led to a slight increase 
in the concentration of tryptophan in plasma (0.1 > P > 0.05), and both short- and long- 
term administration of the hormone led to an increase in the excretion of kynurenine, and a 
reduction in the activity of kynureninase in the liver. Addition of pyridoxal phosphate 
(1 mM) to the incubation mixture led to a 4- to 5-fold increase in the activity of kynureninase, 
with no difference in the total activity of the enzyme between oestrone sulphate-treated 
animals and controls. Oestrone sulphate had no effect on the excretion of "-methyl 
nicotinamide or on the concentration of nicotinamide nuceotides in blood, liver or kidney. 
DISCUSSION 
The results reported here cannot be interpreted as providing support for the hypothesis that 
administration of oestrogens causes depletion or deficiency of vitamin B,. None of the 
indicators of vitamin 8, status assessed showed any effect of the administration of oestrogen 
sulphate. This agrees with the clinical studies cited previously that oestrogen administration 
does not affect the plasma concentration of pyridoxal phosphate, urinary excretion of 
4-pyridoxic acid or the activation of aspartate aminotransferase by pyridoxal phosphate 
(Brown et al. 1975; Leklem et al. 1975; Wien, 1978). It is difficult to explain the increase 
in the plasma concentration of tryptophan in response to prolonged administration of 
oestrone sulphate. It is known that tryptophan oxygenase (L-tryptophan : oxygen oxido- 
reductase (decyclizing), EC 1 .13.11.11) is induced by oestrogens (Patnaik & Sarangi, 
1980), and this would be expected to lead to a reduction in the circulating concentration 
of tryptophan, rather than an increase. A similar effect of oestrogen administration on 
plasma tryptophan has been observed in women receiving either ethinyl oestradiol or 
piperazine oestrone sulphate as menopausal hormone replacement therapy (Bender, 
Papadaki and Coulson, unpublished observations). 
We have reported previously that oestrone sulphate inhibits the enzyme kynureninase 
(Bender & Wynick, 1981). The finding of reduced activity of the holoenzyme in the livers 
of oestrone-sulphate treated rats, and increased urinary excretion of kynurenine, suggests 
that this inhibition, previously demonstrated in vitro, is also important in vivo. The enzyme 
kinetic studies (Bender & Wynick, 1981) suggested that the inhibition of kynureninase was 
competitive with respect to the substrate, and the evidence from the present study indicates 
a similar mode of inhibition in vivo. Although the rats treated with oestrone sulphate 
excreted more kynurenine than did control animals, there was no reduction in their 
excretion of "-methyl nicotinamide, or in the blood and tissue concentrations of 
nicotinamide nucleotides, as might be expected to follow inhibition of kynureninase. This 
suggests a competitive mode of inhibition ; an accumulation of kynurenine, resulting from 
inhibition of the enzyme, will lead to some displacement of the inhibitor from the enzyme, 
and hence will result in more or less normal flux of metabolites through the pathway to 
NAD (and hence to "-methyl nicotinamide), but with a larger than normal intracellular 
pool of kynurenine. 
Treatment with oestrone sulphate seems not to affect the apoenzyme of kynureninase; 
addition of a saturating concentration of pyridoxal phosphate led to a 4- to 5-fold increase 
in enzyme activity, with no difference between oestrogen-treated and control animals. This 
could be explained by competition between the hormone or its metabolites and pyridoxal 
phosphate, as suggested by Mason & Gullekson (1960). However, kinetic studies have 
shown that the inhibition of kynureninase by oestrone sulphate is uncompetitive with 
respect to pyridoxal phosphate (Bender & Wynick, 1981). It therefore appears that oestrone 
sulphate reacts only with the holoenzyme, and not to any significant extent with the 
apoenzyme. 
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A number of studies of women receiving oestrogens as oral contraceptive agents have 
shown that the administration of supplements of vitamin B, will restore tryptophan 
metabolism to normal, and this has been adduced as evidence that the oestrogens cause 
vitamin B, depletion (Rose & Adams, 1972). However, from the results reported here it 
is possible to advance an alternative explanation; there is a considerable amount of 
apo-kynureninase in the liver, as shown by the 4- to 5-fold increase in activity on addition 
of pyridoxal phosphate. Similar activation of a relatively large amount of apo-kynureninase 
in vivo would explain the effect of supplementary vitamin B, in overcoming the effects of 
oestrogens on tryptophan metabolism, regardless of vitamin B, status. 
From the results reported here it seems that the disturbances of tryptophan metabolism 
reported in women receiving oestrogens, which have been attributed to vitamin B, depletion, 
can in fact be accounted for by a direct action of oestrogen metabolites on kynureninqse. 
Although the administration of vitamin B, supplements will increase the activity of 
kynureninase, and hence normalize the metabolism of tryptophan, this does not necessarily 
show that there is a deficiency of the vitamin. 
This study was supported by a grant from the Medical Research Council. 
R E F E R E N C E S  
Adams, E. (1979). Meths. Enzym. 62, 407. 
Aly, H. E., Donald, E. A. & Simpson, M. H. W. (1971). Am. J. clin. Nutr. 24, 297. 
Bender, D.  A. (1980). Biochem. Pharmac. 29, 2099. 
Bender, D. A., Coulson, W. F., Papadaki, L. & Pugh, M. (1981). Proc. Nutr. SOC. 40, 20A. 
Bender, D. A,, Magboul, B. I. & Wynick, D. (1982). Br. J. Nutr. (In the Press). 
Bender, D. A. & Smith, W. R. D. (1978). Biochem. SOC. Trans. 6,  120. 
Bender, D. A. & Wynick, D. (1981). Br. J. Nutr. 45, 269. 
Brown, R. R., Rose, D. P., Leklem, J. E., Linkswiler, H. & Anand, R. (1975). Am. J. clin. Nutr. 28, 10. 
Carpenter, K. J. & Kodicek, E. (1950). Biochem. J .  46, 421. 
Coursin, D. B. (1964). Am. J .  clin. Nutr. 14, 56. 
Denckla, W. D. & Dewey, H. K. (1967). J.  Lab. clin. Med. 69, 160. 
Joseph, M. H. & Risby, D. (1975). Clinica chim. Acra 63, 197. 
Leklem, J. E., Brown, R. R., Rose, D. P. & Linkswiler, H. (1975). Am. J. clin. Nutr. 28, 535. 
Mason, M. & Gullekson, E. H. (1960). J. biol. Chem. 235, 1312. 
Patnaik, S. K. & Sarangi, S. K. (1980). Cell Biol. int. Rep. 4,471. 
Reddy, S .  K., Reynolds, M. S. & Price, J. M. (1958). J .  biol. Chem. 233, 691. 
Rose, D.  P. & Adams, P. W. (1972). J. clin. Path. 25, 252. 
Rose, D. P. & Braidman, I. (1971). Am. J.  clin. Nutr. 24, 673. 
Salkeld, R. L., Knorr, K. & Korner, W. F. (1973). Clinica Chim. Acta 49, 195. 
Satoh, K. & Price, J. M. (1958). J. biol. Chem. 230, 781. 
Schuster, L., Bates, A. & Hirsch, C. A. (1978). Analyt. Biochem. 86, 648. 
Stanulovic, M. & Chaykin, S. (1971). Archs Biochem. Biophys. 145, 27. 
Wien, E. M. (1978). Am. J .  Clin. Nutr. 31, 1392. 
Printed in Great Britain 
